UHS's Supplemental Lifeline and the Outpatient Gambit
De novo drags, malpractice reserves, and exchange attrition cut core growth, but $1.5B in supplemental payments and aggressive buybacks keep the story alive.
UHS · Earnings Call · 2026-07-28
Q2: A Beat That Wasn't Quite
Universal Health Services reported second-quarter adjusted EPS of $5.98, up 12% year-over-year, but the beat was flattered by a non-recurring Florida Medicaid supplemental payment. Excluding that $100 million out-of-period benefit, core EBITDA fell short of internal expectations. CFO Steve Filton laid out the exact shortfall:
When excluding the $100 million out-of-period Florida DPP benefit not contemplated in our guidance, our Q2 adjusted EBITDA less NCI fell short of our internal expectations, primarily attributable to 3 items approximating $63 million — $28 million from higher professional and general liability reserves, $20 million from the San Antonio behavioral facility, and $15 million from a slower ramp at Cedar Hill.
The company cut its full-year EBITDA guidance by roughly $50 million at the midpoint (now $2.61B–$2.72B) and trimmed same-facility volume assumptions in both acute and behavioral. Yet revenue growth remains healthy at ~7%, aided by a growing stream of Medicaid supplemental dollars.
The Supplemental Tailwind
The Florida DPP program, along with other state-directed payments, is becoming a massive swing factor. UHS now expects a net benefit of approximately $1.5 billion for 2026, up $150 million from prior guidance. Steve noted on the call that "more than a fifth of the $1.5 billion total is derived from state-based programs not subject to the reductions in the OBBBA legislation." The One Big Beautiful Bill Act (OBBBA) caps these payments starting in 2028, but the company is banking on a window to adjust. The ~$85 million exchange-related headwind is also contained, though the dynamic is stark: "It felt like virtually everyone who lost their exchange coverage, became an uninsured patient," Filton explained. “It felt like virtually everyone who lost their exchange coverage became an uninsured patient.” — Steve G. Filton, Chief Financial Officer · 2026-07-28
De Novo and Capacity: A Two-Speed Recovery
The Cedar Hill Regional Medical Center in Washington, D.C. remains the biggest drag. Originally expected to be a $50 million tailwind, the guidance now assumes only a $20 million benefit as the hospital reaches breakeven in Q4. "We have been building up the physician component in that region. It takes some time," Filton said on the call. “We have been building up the physician component in that in that region. It takes some time, and, you know, then patients have to sort of you know, reorient their utilization practices, etcetera.” — Steve G. Filton, Chief Financial Officer · 2026-07-28 The company did add 177 licensed beds across three existing facilities, which should ramp faster than a greenfield hospital. These expansions, along with the ongoing ramp of the Palm Beach Gardens de novo, will be key to back-half acceleration.
Outpatient Behavioral: The Next Frontier
The pending Talkspace acquisition (expected to close mid-August) is central to the outpatient growth strategy. Management is positioning it to create the first true end-to-end continuum in behavioral care. As Marc Miller noted in prepared remarks: “Talkspace represents not only a unique opportunity for us to accelerate our presence in the outpatient market, but also creates the nation's first end to end continuum of behavioral health care services.” — Marc D. Miller, President and Chief Executive Officer · 2026-07-28 This pivot toward outpatient is not new—management has been talking about it for over a year. In the July 2025 call, Steve outlined the plan: "We are establishing a larger footprint in freestanding behavioral hospitals that are located generally not on the campuses of our existing hospitals." The goal is to capture more of the step-down and step-in business that has historically flowed to competitors.
Capital Allocation: Buybacks for the Long Haul
With core growth under pressure, UHS is turning to its balance sheet. Share repurchases accelerated to $320 million in Q2, up from $127 million in Q1, and the company plans to remain active. "The recent dislocation in our share price represents a compelling opportunity to deploy capital and retire UHS shares at heavily discounted levels," Miller said. This is supported by a strong balance sheet—net leverage is just 1.8x, and the company has $1.27 billion of revolver capacity. Effective net cash has deteriorated to -$5.2B, but relative to EBITDA, leverage remains comfortable, underpinning the aggressive repurchase program.
The story at UHS is really one of two parts: a one-time supplemental payment boost masking underlying operational challenges, and a deliberate strategic shift toward outpatient behavioral care. The next few quarters will test whether the de novos finally ramp, whether the Florida DPP gets renewed for FY2026, and whether Talkspace can deliver the outsized growth management expects. In the meantime, the buyback provides a floor to the stock.